Disease Markers

Table of Contents: 2012

  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 868029

Apo Lipoprotein A1 Gene Polymorphisms Predict Cardio-Metabolic Risk in South Asian Immigrants

Sunita Dodani | Rebecca Henkhaus | ... | Merlin G. Butler
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 474085

Diagnostic Value of Neopterin during Neutropenic Fever and Determination of Disease Activity in Childhood Leukemias

Fatma Burcu Belen | Ulker Kocak | ... | Turkiz Gursel
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 891859
  • - Erratum

Erratum to Association of GSTM1 and GSTT1 Polymorphism with Lipid Peroxidation in Benign Prostate Hyperplasia and Prostate Cancer: A Pilot Study

Vivek Kumar | Chandra Shekhar Yadav | ... | Basu Dev Banerjee
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 218642

Exon Dosage Variations in Brazilian Patients with Parkinson’s Disease: Analysis of SNCA, PARKIN, PINK1 and DJ-1 Genes

Karla Cristina Vasconcelos Moura | Mário Campos Junior | ... | Márcia Mattos Gonçalves Pimentel
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 497692

Polymorphisms of Glutathione S-Transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) Genes and Epithelial Ovarian Cancer Risk

Cristiane Oliveira | Gustavo Jacob Lourenço | ... | Carmen Silvia Passos Lima
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 215430

Increased Salivary Levels of 8-Hydroxydeoxyguanosine May Be a Marker for Disease Activity for Periodontitis

Ufuk Sezer | Yasin Çiçek | Cenk Fatih Çanakçi
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 194502

In-Vitro Carbofuran Induced Genotoxicity in Human Lymphocytes and Its Mitigation by Vitamins C and E

Ratnesh Kumar Sharma | Bechan Sharma
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 390539

Genetic Association and Gene-gene interaction of HAS2, HABP1 and HYAL3 Implicate Hyaluronan Metabolic Genes in Glaucomatous Neurodegeneration

Kaustuv Basu | Abhijit Sen | ... | Arijit Mukhopadhyay
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 842764

Micro-RNA Expression in the Urinary Sediment of Patients with Chronic Kidney Diseases

Cheuk-Chun Szeto | Kwan Bonnie Ching-Ha | ... | Li Philip Kam-Tao
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 147148
  • - Review

Chemokines and Chemokine Receptors in Susceptibility to HIV-1 Infection and Progression to AIDS

Animesh Chatterjee | Anurag Rathore | ... | Tapan N. Dhole
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 492068

IGF2R Genetic Variants, Circulating IGF2 Concentrations and Colon Cancer Risk in African Americans and Whites

Cathrine Hoyo | Susan K. Murphy | ... | Temitope Keku
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 467085

DJ-1 Variants in Indian Parkinson’s Disease Patients

Tamal Sadhukhan | Arindam Biswas | ... | Jharna Ray
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 429870

Plasma C-Reactive Protein Is Not Related to Sinus Non-Conversion by Maze Procedure Adjunct to Mitral Valve Surgery

Chien-Jen Chen | Wen-Hao Liu | ... | Mien-Cheng Chen
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 430689

Soluble Mesothelin-Related Peptides Levels in Patients with Malignant Mesothelioma

Alenka Franko | Vita Dolzan | ... | Metoda Dodic-Fikfak
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 292507

Association of MTHFR Polymorphisms and Chromosomal Abnormalities in Leukemia

Thivaratana Sinthuwiwat | Phanasit Poowasanpetch | ... | Chintana Tocharoentanaphol
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.